ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants (AQUARiUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02813408
Recruitment Status : Active, not recruiting
First Posted : June 27, 2016
Last Update Posted : February 8, 2018
Sponsor:
Information provided by (Responsible Party):
Janssen Pharmaceutica N.V., Belgium

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2018
  Estimated Study Completion Date : April 2018